Basic Information
| RNALocate ID: | RLID:11002225 |
| RNA Symbol: | hsa-miR-155-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-155-5p |
| RNA ID: | miRBase:MIMAT0000646 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001954 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001955 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11002215 | Exosome | Cell lines (MCF10A|MCF-7|MDA-MB-231) | 25446899 |
| RLID:11002216 | Exosome | NBL cell lines (CHLA-255|IMR-32|SK-N-BE(2)) | 25972604 |
| RLID:11002217 | Exosome | Bronchoalveolar lavage fluid|Pooled sera | 27278097 |
| RLID:11002218 | Exosome | BC cell lines (HCC70|MCF-7|MDA-MB-231) | 30728048 |
| RLID:11002219 | Exosome | Serum | 18589210 |
| RLID:11002220 | Exosome | Plasma | 19289371 |
| RLID:11002221 | Exosome | Human embryonic kidney cell line (HEK-293) | 20353945 |
| RLID:11002222 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11002223 | Exosome | Breast milk | 22211110 |
| RLID:11002224 | Exosome | Brain tissue | 23382797 |
| RLID:11002226 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11002227 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000106 | Exosome | B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Endothelial cells|Lymphoma tissue|Seminal fluid | |
| RLID-D:11000393 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-155-5p | Cardiomyopathies | MNDR-E-MI-17720 |
| MNDR | hsa-miR-155-5p | Diffuse large b cell lymphoma | MNDR-E-MI-17721 |
| MNDR | hsa-miR-155-5p | Splenic marginal zone lymphoma | MNDR-E-MI-17722 |
| MNDR | hsa-miR-155-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-17723 |
| MNDR | hsa-miR-155-5p | Renal fibrosis | MNDR-E-MI-17724 |
| MNDR | hsa-miR-155-5p | Oral squamous cell carcinoma | MNDR-E-MI-17725 |
| MNDR | hsa-miR-155-5p | Follicular cleaved lymphoma | MNDR-E-MI-17726 |
| MNDR | hsa-miR-155-5p | Medulloblastoma | MNDR-E-MI-17727 |
| MNDR | hsa-miR-155-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-17728 |
| MNDR | hsa-miR-155-5p | Lymphoma | MNDR-E-MI-17729 |
| MNDR | hsa-miR-155-5p | Lymphoma non-hodgkin | MNDR-E-MI-17730 |
| MNDR | hsa-miR-155-5p | Cutaneous t cell lymphoma | MNDR-E-MI-17731 |
| MNDR | hsa-miR-155-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-17732 |
| MNDR | hsa-miR-155-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-17733 |
| MNDR | hsa-miR-155-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-17734 |
| MNDR | hsa-miR-155-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-17735 |
| MNDR | hsa-miR-155-5p | Her2-receptor positive breast cancer | MNDR-E-MI-17736 |
| MNDR | hsa-miR-155-5p | Breast cancer luminal | MNDR-E-MI-17737 |
| MNDR | hsa-miR-155-5p | Niemann-pick disease type c | MNDR-E-MI-17738 |
| MNDR | hsa-miR-155-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-17739 |
| MNDR | hsa-miR-155-5p | Colorectal carcinoma | MNDR-E-MI-17740 |
| MNDR | hsa-miR-155-5p | Dermatomyositis | MNDR-E-MI-17741 |
| MNDR | hsa-miR-155-5p | Prostate cancer | MNDR-E-MI-17742 |
| MNDR | hsa-miR-155-5p | Chronic lymphocytic leukemia | MNDR-E-MI-17743 |
| MNDR | hsa-miR-155-5p | Gastric cancer | MNDR-E-MI-17744 |
| MNDR | hsa-miR-155-5p | Pre-eclampsia | MNDR-E-MI-17745 |
| MNDR | hsa-miR-155-5p | Alzheimer disease | MNDR-E-MI-17746 |
| MNDR | hsa-miR-155-5p | Hypertension | MNDR-E-MI-17747 |
| MNDR | hsa-miR-155-5p | Urinary bladder cancer | MNDR-E-MI-17748 |
| MNDR | hsa-miR-155-5p | Trachoma | MNDR-E-MI-17749 |
| MNDR | hsa-miR-155-5p | Dysautonomia familial | MNDR-E-MI-17750 |
| MNDR | hsa-miR-155-5p | Muscular dystrophy duchenne | MNDR-E-MI-17751 |
| MNDR | hsa-miR-155-5p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-17752 |
| MNDR | hsa-miR-155-5p | Head and neck cancer | MNDR-E-MI-17753 |
| MNDR | hsa-miR-155-5p | Leukemia | MNDR-E-MI-17754 |
| MNDR | hsa-miR-155-5p | Friedreich ataxia | MNDR-E-MI-17755 |
| MNDR | hsa-miR-155-5p | Cardiovascular disease | MNDR-E-MI-17756 |
| MNDR | hsa-miR-155-5p | Miller fisher syndrome | MNDR-E-MI-17757 |
| MNDR | hsa-miR-155-5p | Dilated cardiomyopathy | MNDR-E-MI-17758 |
| MNDR | hsa-miR-155-5p | Focal segmental glomerulosclerosis | MNDR-E-MI-17759 |
| MNDR | hsa-miR-155-5p | Brain cancer | MNDR-E-MI-17760 |
| MNDR | hsa-miR-155-5p | Lung cancer | MNDR-E-MI-17761 |
| MNDR | hsa-miR-155-5p | Giant cell arteritis | MNDR-E-MI-17762 |
| MNDR | hsa-miR-155-5p | Kawasaki disease | MNDR-E-MI-17763 |
| MNDR | hsa-miR-155-5p | Tuberous sclerosis | MNDR-E-MI-17764 |
| MNDR | hsa-miR-155-5p | Endometrial cancer | MNDR-E-MI-17765 |
| MNDR | hsa-miR-155-5p | Malaria cerebral | MNDR-E-MI-17766 |
| MNDR | hsa-miR-155-5p | Down syndrome | MNDR-E-MI-17767 |
| MNDR | hsa-miR-155-5p | Parkinson disease | MNDR-E-MI-17768 |
| MNDR | hsa-miR-155-5p | Niemann-pick disease | MNDR-E-MI-17769 |
| MNDR | hsa-miR-155-5p | Basal-like breast cancer | MNDR-E-MI-17770 |
| MNDR | hsa-miR-155-5p | Cancer | MNDR-E-MI-17771 |
| MNDR | hsa-miR-155-5p | Coronary stenotic lesions | MNDR-E-MI-17772 |
| MNDR | hsa-miR-155-5p | Pituitary neoplasms | MNDR-E-MI-17773 |
| MNDR | hsa-miR-155-5p | Pancreatic cancer | MNDR-E-MI-17774 |
| MNDR | hsa-miR-155-5p | Hepatitis C | MNDR-E-MI-17775 |
| MNDR | hsa-miR-155-5p | Melanoma | MNDR-E-MI-17776 |
| MNDR | hsa-miR-155-5p | Atherosclerosis | MNDR-E-MI-17777 |
| MNDR | hsa-miR-155-5p | Rectum adenocarcinoma | MNDR-E-MI-17778 |
| MNDR | hsa-miR-155-5p | Hepatitis B | MNDR-E-MI-17779 |
| MNDR | hsa-miR-155-5p | Nephroblastoma | MNDR-E-MI-17780 |
| MNDR | hsa-miR-155-5p | Colon cancer | MNDR-E-MI-17781 |
| MNDR | hsa-miR-155-5p | Multiple sclerosis | MNDR-E-MI-17782 |
| MNDR | hsa-miR-155-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-17783 |
| MNDR | hsa-miR-155-5p | Thyroid adenomas | MNDR-E-MI-17784 |
| MNDR | hsa-miR-155-5p | Pulmonary tuberculosis | MNDR-E-MI-17785 |
| MNDR | hsa-miR-155-5p | Carcinoma ductal breast | MNDR-E-MI-17786 |
| MNDR | hsa-miR-155-5p | Glioblastoma | MNDR-E-MI-17787 |
| MNDR | hsa-miR-155-5p | Astrocytoma | MNDR-E-MI-17788 |
| MNDR | hsa-miR-155-5p | Glioma | MNDR-E-MI-17789 |
| MNDR | hsa-miR-155-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-17790 |
| MNDR | hsa-miR-155-5p | Oligodendroglioma | MNDR-E-MI-17791 |
| MNDR | hsa-miR-155-5p | Nemaline myopathy | MNDR-E-MI-17792 |
| MNDR | hsa-miR-155-5p | Central nervous system lymphoma | MNDR-E-MI-17793 |
| MNDR | hsa-miR-155-5p | Chordoma | MNDR-E-MI-17794 |
| MNDR | hsa-miR-155-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-17795 |
| MNDR | hsa-miR-155-5p | Epilepsy temporal lobe | MNDR-E-MI-17796 |
| MNDR | hsa-miR-155-5p | Osteosarcoma | MNDR-E-MI-17797 |
| MNDR | hsa-miR-155-5p | Liposarcoma | MNDR-E-MI-17798 |
| MNDR | hsa-miR-155-5p | Coronary artery disease | MNDR-E-MI-17799 |
| MNDR | hsa-miR-155-5p | Inclusion body myositis | MNDR-E-MI-17800 |
| MNDR | hsa-miR-155-5p | Breast carcinoma | MNDR-E-MI-17801 |
| MNDR | hsa-miR-155-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-17802 |
| MNDR | hsa-miR-155-5p | Meningioma | MNDR-E-MI-17803 |
| MNDR | hsa-miR-155-5p | Gastric adenocarcinoma | MNDR-E-MI-17804 |
| MNDR | hsa-miR-155-5p | Pituitary adenoma | MNDR-E-MI-17805 |
| MNDR | hsa-miR-155-5p | Lung squamous cell carcinoma | MNDR-E-MI-17806 |
| MNDR | hsa-miR-155-5p | Carcinoma lung non-small-cell | MNDR-E-MI-17807 |
| MNDR | hsa-miR-155-5p | Lung adenocarcinoma | MNDR-E-MI-17808 |
| MNDR | hsa-miR-155-5p | Acute myocarditis | MNDR-E-MI-17809 |
| MNDR | hsa-miR-155-5p | Thyroid carcinoma | MNDR-E-MI-17810 |
| MNDR | hsa-miR-155-5p | Papillary thyroid carcinoma | MNDR-E-MI-17811 |
| MNDR | hsa-miR-155-5p | Pancreatic adenocarcinoma | MNDR-E-MI-17812 |
| MNDR | hsa-miR-155-5p | Liver disease | MNDR-E-MI-17813 |
| MNDR | hsa-miR-155-5p | Scleroderma | MNDR-E-MI-17814 |
| MNDR | hsa-miR-155-5p | Cervical cancer | MNDR-E-MI-17815 |
| MNDR | hsa-miR-155-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-17816 |
| MNDR | hsa-miR-155-5p | Carcinoma renal cell | MNDR-E-MI-17817 |
| MNDR | hsa-miR-155-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-17818 |
| MNDR | hsa-miR-155-5p | Clear cell renal cell carcinoma | MNDR-E-MI-17819 |
| MNDR | hsa-miR-155-5p | Uremia | MNDR-E-MI-17820 |
| MNDR | hsa-miR-155-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-17821 |
| MNDR | hsa-miR-155-5p | Cholangiocarcinoma | MNDR-E-MI-17822 |
| MNDR | hsa-miR-155-5p | Esophageal cancer | MNDR-E-MI-17823 |
| MNDR | hsa-miR-155-5p | Chronic inflammatory demyelinating polyradiculoneuropathy | MNDR-E-MI-17824 |
| MNDR | hsa-miR-155-5p | HIV | MNDR-E-MI-17825 |
| MNDR | hsa-miR-155-5p | Stomach carcinoma | MNDR-E-MI-17826 |
| MNDR | hsa-miR-155-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-17827 |
| MNDR | hsa-miR-155-5p | Heart failure | MNDR-E-MI-17828 |
| MNDR | hsa-miR-155-5p | Adenoma | MNDR-E-MI-17829 |
| MNDR | hsa-miR-155-5p | Breast invasive carcinoma | MNDR-E-MI-17830 |
| MNDR | hsa-miR-155-5p | Juvenile rheumatoid arthritis | MNDR-E-MI-17831 |
| MNDR | hsa-miR-155-5p | Hepatocelluar carcinoma | MNDR-E-MI-17832 |
| MNDR | hsa-miR-155-5p | B-cell lymphoma | MNDR-E-MI-17833 |
| MNDR | hsa-miR-155-5p | Ankylosing spondylitis | MNDR-E-MI-17834 |
| MNDR | hsa-miR-155-5p | Rheumatoid arthritis | MNDR-E-MI-17835 |
| MNDR | hsa-miR-155-5p | T-cell leukemia | MNDR-E-MI-17836 |
| MNDR | hsa-miR-155-5p | Malignant pleural mesothelioma | MNDR-E-MI-17837 |
| MNDR | hsa-miR-155-5p | Chronic kidney disease | MNDR-E-MI-17838 |
| MNDR | hsa-miR-155-5p | Chronic myeloid leukemia | MNDR-E-MI-17839 |
| MNDR | hsa-miR-155-5p | Hodgkin disease | MNDR-E-MI-17840 |
| MNDR | hsa-miR-155-5p | Ulcerative colitis | MNDR-E-MI-17841 |
| MNDR | hsa-miR-155-5p | Burkitt lymphoma | MNDR-E-MI-17842 |
| MNDR | hsa-miR-155-5p | Mouth neoplasms | MNDR-E-MI-17843 |
| MNDR | hsa-miR-155-5p | Crohn disease | MNDR-E-MI-17844 |
| MNDR | hsa-miR-155-5p | Intermediate coronary syndrome | MNDR-E-MI-17845 |
| MNDR | hsa-miR-155-5p | Tonsil cancer | MNDR-E-MI-17846 |
| MNDR | hsa-miR-155-5p | Skin cutaneous melanoma | MNDR-E-MI-17847 |
| MNDR | hsa-miR-155-5p | Skin melanoma | MNDR-E-MI-17848 |
| MNDR | hsa-miR-155-5p | Subacute sclerosing panencephalitis | MNDR-E-MI-17849 |
| MNDR | hsa-miR-155-5p | Systemic lupus erythematosus | MNDR-E-MI-17850 |
| MNDR | hsa-miR-155-5p | Acute myelocytic leukemia | MNDR-E-MI-17851 |
| MNDR | hsa-miR-155-5p | Colorectal cancer | MNDR-E-MI-17852 |
| MNDR | hsa-miR-155-5p | Nasopharyngeal carcinoma | MNDR-E-MI-17853 |
| MNDR | hsa-miR-155-5p | Multiple myeloma | MNDR-E-MI-17854 |
| MNDR | hsa-miR-155-5p | Ovarian epithelial cancer | MNDR-E-MI-17855 |
| MNDR | hsa-miR-155-5p | Cardiomegaly | MNDR-E-MI-17856 |
| MNDR | hsa-miR-155-5p | Inflammation | MNDR-E-MI-17857 |
| MNDR | hsa-miR-155-5p | Nasopharyngeal cancer | MNDR-E-MI-17858 |
| MNDR | hsa-miR-155-5p | Wounds and injuries | MNDR-E-MI-17859 |
| MNDR | hsa-miR-155-5p | Polymyositis | MNDR-E-MI-17860 |
| MNDR | hsa-miR-155-5p | Epstein-barr virus infections | MNDR-E-MI-17861 |
| MNDR | hsa-miR-155-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-17862 |
| MNDR | hsa-miR-155-5p | Gait ataxia | MNDR-E-MI-17863 |
| MNDR | hsa-miR-155-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-17864 |
| MNDR | hsa-miR-155-5p | Lung injury | MNDR-E-MI-17865 |
| MNDR | hsa-miR-155-5p | Plaque atherosclerotic | MNDR-E-MI-17866 |
| MNDR | hsa-miR-155-5p | Breast cancer her3+ negative | MNDR-E-MI-17867 |
| MNDR | hsa-miR-155-5p | Tubulovillous adenoma | MNDR-E-MI-17868 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACTR2 | Homo sapiens | RR00038256 |
TOP